- In October 2023, Philips announced the results of the largest-ever analysis of real-world long-term data comparing Instantaneous Wave-Free Ratio (IFR) and Fractional Flow Reserve (FFR) in diagnosing and treating heart disease. The study demonstrated that both IFR and FFR are equally safe and effective for use in clinical practice. This finding is expected to benefit healthcare providers by offering greater flexibility in selecting diagnostic methods, potentially reducing the need for invasive procedures while maintaining accuracy in identifying coronary artery disease. It also provides long-term data to support better decision-making in cardiovascular care
- In November 2024, Boston Scientific launched its multi-functional imaging system, Avvigo. The system is designed to provide advanced imaging capabilities for cardiovascular procedures, particularly in guiding interventions for coronary artery disease. The launch aims to enhance clinical decision-making by offering real-time, high-definition imaging that allows for improved visualization during complex procedures. Avvigo is expected to benefit healthcare professionals by improving procedural accuracy, reducing the risk of complications, and optimizing patient outcomes. This innovative imaging system is poised to support a wide range of interventions, streamlining workflows and enhancing overall efficiency in cardiovascular care
